Escherichia coli, J&J and Sanofi
A comprehensive seven-year study across 20 Chinese provinces has revealed a concerning rise in antimicrobial resistance (AMR) ...
An E coli infection linked to the death of a doctor in Princess Margaret Hospital is unlikely to lead to widespread ...
By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in ...
The skin serves as the body's primary defense against harmful microorganisms, toxins, and physical damage. However, severe ...
Escherichia coli, commonly known as E. coli, is a versatile bacterium. While many strains are harmless and a natural part of our intestinal ...
Protein complex in bacterial cell membrane acts like a rotary motor to recruit DNA-degrading enzymes to defend against phage ...
7don MSN
A new study published in Biochemistry sheds light on how bacteria regulate their genes, challenging long-held assumptions ...
The Centre for Health Protection is looking into a suspected Shiga toxin-producing Escherichia coli infection cluster ...
22h
Newsable Asianet News on MSN205 Guillain-Barre Syndrome cases detected in Maharashtra, death toll rises to 8Maharashtra Health Department said, "A total of 205 suspected patients have been detected till date. Of these, 177 patients ...
13don MSN
Suspected Guillain-Barré Syndrome (GBS) deaths in Maharashtra rise to four, with E.coli found in water samples in Pune.
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.
Johnson & Johnson said on Thursday it will discontinue a late-stage study of an experimental E.coli vaccine it was developing in partnership with Sanofi. The drugmaker said its decision was based on t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results